• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铜蓝蛋白和脂褐素血清浓度与肥厚型心肌病的存在相关。

Ceruloplasmin and Lipofuscin Serum Concentrations Are Associated with Presence of Hypertrophic Cardiomyopathy.

作者信息

Smyła-Gruca Wiktoria, Szczurek-Wasilewicz Wioletta, Skrzypek Michał, Romuk Ewa, Karmański Andrzej, Jurkiewicz Michał, Gąsior Mariusz, Osadnik Tadeusz, Banach Maciej, Jóźwiak Jacek J, Szyguła-Jurkiewicz Bożena

机构信息

Student's Scientific Society, 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.

2nd Department of Cardiology and Angiology, Silesian Center for Heart Diseases, 41-800 Zabrze, Poland.

出版信息

Biomedicines. 2024 Aug 6;12(8):1767. doi: 10.3390/biomedicines12081767.

DOI:10.3390/biomedicines12081767
PMID:39200231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11352126/
Abstract

Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species and cells' ability to neutralize them by antioxidant systems. The role of oxidative stress in hypertrophic cardiomyopathy (HCM) is not fully understood. The aim of the study was to examine selected parameters of oxidative stress in patients with HCM compared to the control group. We enrolled 85 consecutive HCM patients and 97 controls without HCM. The groups were matched for sex, the body mass index, and age. Oxidative stress markers included superoxide dismutase (SOD), ceruloplasmin (CER), and lipofuscin (LPS). The median age of the HCM patients was 53 (40-63) years, and 41.2% of them were male. HCM patients, compared to the control ones, had significantly increased levels of CER and LPS. The areas under the receiver operating characteristics curves (AUC) indicated a good discriminatory power of CER (AUC 0.924, sensitivity 84%, and specificity 88%), an acceptable discriminatory power of LPS (AUC 0.740, sensitivity 66%, and specificity 72%), and poor discriminatory power of SOD (AUC 0.556, sensitivity 34%, and specificity 94%) for HCM detection. CER with good predictive strength, as well as LPS with acceptable predictive power, allows for HCM detection. The utility of SOD for HCM detection is limited.

摘要

氧化应激反映了活性氧的全身表现与细胞通过抗氧化系统中和它们的能力之间的失衡。氧化应激在肥厚型心肌病(HCM)中的作用尚未完全明确。本研究的目的是比较肥厚型心肌病患者与对照组氧化应激的选定参数。我们连续纳入了85例肥厚型心肌病患者和97例非肥厚型心肌病对照组。两组在性别、体重指数和年龄方面相匹配。氧化应激标志物包括超氧化物歧化酶(SOD)、铜蓝蛋白(CER)和脂褐素(LPS)。肥厚型心肌病患者的中位年龄为53(40 - 63)岁,其中41.2%为男性。与对照组相比,肥厚型心肌病患者的CER和LPS水平显著升高。受试者工作特征曲线(AUC)下面积表明,CER对肥厚型心肌病检测具有良好的鉴别能力(AUC 0.924,敏感性84%,特异性88%),LPS具有可接受的鉴别能力(AUC 0.740,敏感性66%,特异性72%),而SOD的鉴别能力较差(AUC 0.556,敏感性34%,特异性94%)。具有良好预测强度的CER以及具有可接受预测能力的LPS可用于肥厚型心肌病检测。SOD用于肥厚型心肌病检测的效用有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aeb/11352126/a0cab0538380/biomedicines-12-01767-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aeb/11352126/6aa9e0acfab3/biomedicines-12-01767-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aeb/11352126/a0cab0538380/biomedicines-12-01767-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aeb/11352126/6aa9e0acfab3/biomedicines-12-01767-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aeb/11352126/a0cab0538380/biomedicines-12-01767-g002.jpg

相似文献

1
Ceruloplasmin and Lipofuscin Serum Concentrations Are Associated with Presence of Hypertrophic Cardiomyopathy.铜蓝蛋白和脂褐素血清浓度与肥厚型心肌病的存在相关。
Biomedicines. 2024 Aug 6;12(8):1767. doi: 10.3390/biomedicines12081767.
2
Oxidative Stress Markers in Hypertrophic Cardiomyopathy.肥厚型心肌病的氧化应激标志物。
Medicina (Kaunas). 2021 Dec 24;58(1):31. doi: 10.3390/medicina58010031.
3
Antioxidant defence and oxidative stress markers in cats with asymptomatic and symptomatic hypertrophic cardiomyopathy: a pilot study.抗氧化防御和无症状与有症状肥厚型心肌病猫的氧化应激标志物:一项初步研究。
BMC Vet Res. 2020 Jan 30;16(1):26. doi: 10.1186/s12917-020-2256-3.
4
Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.二维超声图像未见肥厚改变的肥厚型心肌病基因突变阳性患儿心尖旋转的早期变化。
J Am Soc Echocardiogr. 2014 Feb;27(2):215-21. doi: 10.1016/j.echo.2013.10.012. Epub 2013 Dec 8.
5
Detection of hypertrophic cardiomyopathy by an artificial intelligence electrocardiogram in children and adolescents.人工智能心电图在儿童和青少年肥厚型心肌病中的检测。
Int J Cardiol. 2021 Oct 1;340:42-47. doi: 10.1016/j.ijcard.2021.08.026. Epub 2021 Aug 19.
6
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers.心脏磁共振特征追踪技术可识别肥厚型心肌病肌节基因突变携带者的临床前异常。
Circ Cardiovasc Imaging. 2024 Apr;17(4):e016042. doi: 10.1161/CIRCIMAGING.123.016042. Epub 2024 Apr 2.
7
The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy.心肌磁共振成像衍生的心肌纤维化参数在肥厚型心肌病患者危险分层中的价值。
Acad Radiol. 2023 Sep;30(9):1962-1978. doi: 10.1016/j.acra.2022.12.026. Epub 2023 Jan 3.
8
Enhanced oxidative stress in hypertrophic cardiomyopathy.肥厚型心肌病中氧化应激增强。
Pharmacol Rep. 2009 May-Jun;61(3):491-5. doi: 10.1016/s1734-1140(09)70091-x.
9
Tricuspid annular motion velocity as a differentiation index of hypertrophic cardiomyopathy from hypertensive heart disease.三尖瓣环运动速度作为肥厚型心肌病与高血压性心脏病的鉴别指标。
J Cardiol. 2015 Jun;65(6):519-25. doi: 10.1016/j.jjcc.2014.08.005. Epub 2014 Sep 8.
10
Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation study.国际队列中基于人工智能心电图检测肥厚型心肌病:一项外部验证研究
Eur Heart J Digit Health. 2024 Apr 15;5(4):416-426. doi: 10.1093/ehjdh/ztae029. eCollection 2024 Jul.

本文引用的文献

1
2023 ESC Guidelines for the management of cardiomyopathies.2023年欧洲心脏病学会心肌病管理指南。
Eur Heart J. 2023 Oct 1;44(37):3503-3626. doi: 10.1093/eurheartj/ehad194.
2
Inflammation across the spectrum of hypertrophic cardiac phenotypes.从肥厚型心脏表型的炎症谱看问题
Heart Fail Rev. 2023 Sep;28(5):1065-1075. doi: 10.1007/s10741-023-10307-4. Epub 2023 Apr 28.
3
Copper chelation in patients with hypertrophic cardiomyopathy.铜螯合治疗肥厚型心肌病。
Open Heart. 2022 Feb;9(1). doi: 10.1136/openhrt-2021-001803.
4
Oxidative Stress Markers in Hypertrophic Cardiomyopathy.肥厚型心肌病的氧化应激标志物。
Medicina (Kaunas). 2021 Dec 24;58(1):31. doi: 10.3390/medicina58010031.
5
Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy.肥厚型心肌病中心脏能量代谢改变和线粒体功能障碍。
Circulation. 2021 Nov 23;144(21):1714-1731. doi: 10.1161/CIRCULATIONAHA.121.053575. Epub 2021 Oct 21.
6
Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy.应激激活的信号通路损害了人类肥厚型心肌病中的蛋白质质量控制途径。
Int J Cardiol. 2021 Dec 1;344:160-169. doi: 10.1016/j.ijcard.2021.09.009. Epub 2021 Sep 10.
7
The molecular and cellular basis of copper dysregulation and its relationship with human pathologies.铜失调的分子和细胞基础及其与人类病理学的关系。
FASEB J. 2021 Sep;35(9):e21810. doi: 10.1096/fj.202100273RR.
8
Reducing lipofuscin accumulation and cardiomyocytic senescence of aging heart by enhancing autophagy.通过增强自噬来减少衰老心脏中的脂褐素积累和心肌细胞衰老。
Exp Cell Res. 2021 Jun 1;403(1):112585. doi: 10.1016/j.yexcr.2021.112585. Epub 2021 Mar 31.
9
The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study.波兰初级保健患者中心血管风险因素和心血管疾病的流行情况:来自 LIPIDOGRAM2015 研究的结果。
Atheroscler Suppl. 2020 Dec;42:e15-e24. doi: 10.1016/j.atherosclerosissup.2021.01.004.
10
Oxidative Stress in Cell Death and Cardiovascular Diseases.细胞死亡与心血管疾病中的氧化应激。
Oxid Med Cell Longev. 2019 Nov 4;2019:9030563. doi: 10.1155/2019/9030563. eCollection 2019.